Latest filing published 27 Feb 2012 for Targeted Medical Pharma, Inc., €55k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Amir F. Heshmatpour: trading record in brief
This profile gathers the share dealings of Amir F. Heshmatpour across 12 companies, led by Emmaus Life Sciences, Inc., Targeted Medical Pharma, Inc. and AFH Acquisition V, Inc. Over a trading history stretching from 13 November 2007 to 7 February 2012, the count stands at 46 filings.
In open-market terms, that means 2 purchases worth €17k on one side and 16 sales worth €4.0B on the other. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. So far in 2012, the count stands at no purchases and 3 sales.
On 27 February 2012 came the latest disclosure, an open-market sale for €55k in Targeted Medical Pharma, Inc. The latest purchase dates back some time: it was published 6,934 days ago, on 14 November 2007. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amir F. Heshmatpour
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,477 shares@ US$2.65Common Stock, $.001 par valueSEC:0001437904-12-000010:0
- 202,250 shares0Common Stock, $.001 par valueSEC:0001437904-12-000009:1
- 16,800 shares@ US$3.57Common Stock, $.001 par valueSEC:0001437904-12-000002:0
- 2,500,000 shares@ US$0.04Common Stock, $.001 par valueSEC:0001437904-11-000128:0
- 112,001 shares@ US$3.5714Common StockSEC:0001387131-11-002705:0
- 11,200 shares@ US$3.5714Common StockSEC:0001387131-11-002705:2
- 28,000 shares@ US$3.5714Common StockSEC:0001387131-11-001928:0
- 28,000 shares@ US$100,000.00Common StockSEC:0001387131-11-001232:0
- 1,827,750 shares0Common StockSEC:0001140361-11-025443:0
- 500,000 shares0Common StockSEC:0001140361-11-025443:1
- 300,000 sharesCommon StockSEC:0001387131-11-000668:2
- 300,000 sharesCommon StockSEC:0001387131-11-000668:0
- 300,000 sharesCommon StockSEC:0001387131-11-000668:1
- 500,000 shares@ US$0.025Common Stock, par value $.001SEC:0001140361-11-006192:0
- 150,000 shares@ US$2.55Common Stock, par value $.001SEC:0001140361-11-006192:1
- 470,150 shares@ US$1.00Common Stock, par value $.001SEC:0001140361-11-006192:2
- 2,275,000 shares0Common Stock, par value $.001SEC:0001140361-11-006192:3
- 700,000 sharesCommon StockSEC:0001144204-10-029081:0
- 2,870,000 shares0Common StockSEC:0001140361-08-019769:0
- 5,000,000 shares0Common Stock, par value $.001 per share (the "Common Stock")SEC:0001144204-08-044943:0
- 5,000,000 shares0Common StockSEC:0001144204-08-044943:1
- 5,000,000 shares0Common Stock, par value $.001 per share (the "Common Stock")SEC:0001144204-08-044926:0
- 5,000,000 shares0Common StockSEC:0001144204-08-044926:1
- 5,000,000 shares0Common Stock, par value $.001 per share (the "Common Stock")SEC:0001144204-08-044932:0
- 5,000,000 shares0Common StockSEC:0001144204-08-044932:1
25 of 41 declarations
